Adenoviral gene therapy in hepatocellular carcinoma: A review

Hepatology International

Volumn 7, Issue 1, 2013, Pages 48-58

  Lyra González, Iván ^a   Flores Fong, Laura Esther ^a   González García, Ignacio ^b   Medina Preciado, David ^b   Armendáriz Borunda, Juan ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

Adenoviral gene therapy; Cancer treatment; Gene therapy; HCC; Hepatocellular carcinoma; Liver cancer

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; ALPHA INTERFERON; ANGIOSTATIN; CD40 LIGAND; CHONDROMODULIN 1; E1B PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN; HEPATITIS B VIRUS X PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INTERLEUKIN 12; INTERLEUKIN 24; JANUS KINASE; MICRORNA 122; OSTEONECTIN; PARVOVIRUS VECTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREALBUMIN; PROTEIN BAX; PROTEIN BID; PROTEIN P53; SITIMAGENE CERADENOVEC; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TUMOR ENDOTHELIAL MARKER 8; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIANGIOGENIC ACTIVITY; CANCER RESEARCH; CANCER SURVIVAL; DRUG CYTOTOXICITY; DRUG POTENTIATION; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84875235562     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9367-2     Document Type: Review

References (122)

1. DM Parkin F Bray J Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108 15761078
2. AI Gomma SA Khan MB Toledano, et al. 2008 Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis World J Gastroenterol 14 27 4300 4308
3. PA Farazi J Glickman S Jiang, et al. 2003 Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma Cancer Res 63 16 5021 5027 12941829 1:CAS:528:DC%2BD3sXms12nsLc%3D
4. F Trevisani MC Cantarini JR Wands, et al. 2008 Recent advances in the natural history of hepatocellular carcinoma Carcinogenesis 29 7 1299 1305 18515282 1:CAS:528:DC%2BD1cXpslars7Y%3D
5. B Rampone B Schiavone A Martino, et al. 2009 Current management strategy of hepatocelluar carcinoma World J Gastroenterol 15 26 3210 3216 19598295 1:CAS:528:DC%2BD1MXpsF2rurY%3D
6. GK Abou-Alfa FD Huitzil-Melendez EM O'Reilly, et al. 2008 Current management of advanced hepatocellular carcinoma Gastrointest Cancer Res 2 64 70 19259298
7. BQ Starley CJ Calcagno SA Harrison 2010 Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 5 1820 1832 20432259
8. M Elmberg R Hultcrantz A Ekbom, et al. 2003 Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives Gastroenterology 125 1733 1742 14724826
9. AW Hsing JK McLaughlin HJ Olsen, et al. 1995 Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark Int J Cancer 60 160 162 7829208 1:STN:280:DyaK2M7jtVahtg%3D%3D
10. AL Fracanzani D Conte M Fraquelli, et al. 2001 Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease Hepatology 33 647 651 11230745 1:STN:280:DC%2BD3M3gs1SnsQ%3D%3D
11. T Nussbaum J Samarin V Ehemann, et al. 2008 Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis Hepatology 48 1 146 156 18537183 1:CAS:528: DC%2BD1cXptFemurw%3D
12. HO Adami WH Chow O Nyren, et al. 1996 Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 88 20 1472 1477 8841022 1:STN:280:DyaK28vjvVKlsA%3D%3D
13. F Donato A Tagger U Gelatti, et al. 2002 Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women Am J Epidemiol 155 323 331 11836196 1:STN:280:DC%2BD387ltVOmtg%3D%3D
14. PC Hsiao MK Chen SC Su, et al. 2010 Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma J Surg Oncol 102 2 163 169 20648588 1:CAS:528:DC%2BC3cXhtFahsbnE
15. S Maheshwari A Sarraj J Kramer, et al. 2007 Oral contraception and the risk of hepatocellular carcinoma J Hepatol 47 4 506 513 17462781 1:CAS:528:DC%2BD2sXpvF2msLc%3D
16. HC Wu Q Wang HI Yang, et al. 2009 Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan Cancer Epidemiol Biomarkers Prev 18 3 846 853 19273485 1:CAS:528:DC%2BD1MXivVOlsLc%3D
17. R Mondragon-Sanchez E Gomez-Gomez MN Martinez-Gonzalez 2004 Hepatocarcinoma: Algoritmo de conducta terapéutica Rev Gastroenterol Mex 69 3 155 159 16881222
18. SD Ryder 2003 Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Gut 52 3 1 8
19. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 5 1208 1236 16250051
20. MR Aljabiri F Lodato AK Burroughs 2007 Surveillance and diagnosis for hepatocellular carcinoma Liver Transpl 13 11 suppl 2 s2 s12 17969087
21. M Voiculescu RE Winkler M Moscovici, et al. 2008 Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic J Gastrointest Liver Dis 17 3 315 322
22. T Yau P Chan R Epstein, et al. 2008 Evolution of systemic therapy of advanced hepatocellular carcinoma World J Gastroenterol 14 42 6437 6441 19030192
23. S Parikh D Hyman 2007 Hepatocellular cancer: a guide for the internist Am J Med 120 194 202 17349437
24. N Walzer LM Kulik 2008 Hepatocellular carcinoma: latest developments Curr Opin Gastroenterol 24 312 319 18408459
25. Y Wang F Huang H Cai, et al. 2010 The efficacy of combination therapy using adeno-associated virus-TRIAL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma J Cancer Res Clin Oncol 136 1827 1837 20213096 1:CAS:528:DC%2BC3cXhtlaqtLzP
26. PW Szlosarek AG Dalgleish 2000 Potential applications of gene therapy in a patient with cancer Drugs Aging 17 121 132 10984200 1:CAS:528: DC%2BD3cXmtFOit78%3D
27. CT Xu BR Pan 1998 Current status of gene therapy in gastroenterology World J Gastroenterol 4 85 89 11819242
28. AG Knudson 2001 Two genetic hits (more or less) to cancer Nat Rev Cancer 1 157 162 11905807 1:CAS:528:DC%2BD38XlvF2qsLg%3D
29. A Lachenmayer C Alsinet CY Chang, et al. 2010 Molecular approaches to treatment of hepatocellular carcinoma Dig Liver Dis 42 suppl 3 s264 s272 20547313 1:CAS:528:DC%2BC3cXpsVGgsbc%3D
30. B Minguez V Tovar D Chiang, et al. 2009 Pathogenesis of hepatocellular carcinoma and molecular therapies Curr Opin Gastroenterol 25 3 186 194 19387255 1:CAS:528:DC%2BD1MXkvVGlsr4%3D
31. PA Farazi RA DePinho 2006 Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 674 687 16929323 1:CAS:528: DC%2BD28XosVOmsLs%3D
32. SS Thorgeirsson JW Grisham 2002 Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 339 346 12149612 1:CAS:528: DC%2BD38Xls1Oku7c%3D
33. J Bruix L Boix M Sala, et al. 2004 Focus on hepatocellular carcinoma Cancer Cell 5 215 219 15050913 1:CAS:528:DC%2BD2cXjtVartbs%3D
34. A Villanueva P Newell D Chiang, et al. 2007 Genes and signaling pathways involved in the pathogenesis of HCC Semin Liver Dis 27 55 76 17295177 1:CAS:528:DC%2BD2sXjtlWrsLs%3D
35. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanisms, and function Cell 116 281 297 14744438 1:CAS:528:DC%2BD2cXhtVals7o%3D
36. M Fabbri GA Calin 2010 Epigenetics and miRNAs in human cancer Adv Genet 70 87 99 20920746 1:CAS:528:DC%2BC3cXhs1SisrfL
37. SR Viswanathan GQ Daley 2010 Lin28: a microRNA regulator with a macro role Cell 140 4 445 449 20178735 1:CAS:528:DC%2BC3cXlt1Kltrw%3D
38. E Elyakim E Sitbon A Faerman, et al. 2010 hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy Cancer Res 70 20 8077 8087 20924108 1:CAS:528:DC%2BC3cXht1yqs7bE
39. D Kirn I Niculescu-Duvaz G Hallden, et al. 2002 The emerging fields of suicide gene therapy and virotherapy Trends Mol Med 8 suppl 4 S68 S73 11927291 1:CAS:528:DC%2BD38XitlGhsbw%3D
40. TW Hermiston I Kuhn 2002 Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes Cancer Gene Ther 9 12 1022 1035 12522441 1:CAS:528:DC%2BD3sXhs1Oiug%3D%3D
41. W Walther U Stein 1999 Therapeutic genes for cancer gene therapy Mol Biotechnol 13 21 28 10934519 1:CAS:528:DC%2BD3cXoslSlsQ%3D%3D
42. N Somia IM Verma 2000 Gene therapy: trials and tribulations Nat Rev Genet 1 91 99 11253666 1:CAS:528:DC%2BD3cXosFCksbs%3D
43. P Anklesaria 2000 Gene therapy: a molecular approach to cancer treatment Curr Opin Mol Ther 2 426 432 11249773 1:CAS:528:DC%2BD3cXmtl2qt74%3D
44. HS Pandha LA Martin AS Rigg, et al. 2000 Gene therapy: recent progress in the clinical oncology arena Curr Opin Mol Ther 2 362 375 11249766 1:CAS:528:DC%2BD3cXmtl2qtro%3D
45. R Hernandez-Alcoceba B Sangro J Prieto 2006 Gene therapy of liver cáncer World J Gastroenterol 12 38 6085 6097 17036377 1:CAS:528:DC%2BD28Xht1emt7fP
46. T Rothmann A Hengstermann NJ Whitaker, et al. 1998 Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells J Virol 72 12 9470 9478 9811680 1:CAS:528:DyaK1cXnsF2htrw%3D
47. JF Engelhardt X Ye B Doranz, et al. 1994 Ablation of E2 in recombinant adenoviruses improves transgene persistence and decrease inflammatory response in mouse liver Proc Natl Acad Sci USA 91 13 6196 6200 8016137 1:CAS:528:DyaK2cXkslCktbw%3D
48. C Crowther A Ely J Hornby, et al. 2008 Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors Hum Gene Ther 19 11 1325 1331 19848584 1:CAS:528:DC%2BD1cXhsVKls7vE
49. Q Cui W Jiang Y Wang, et al. 2008 Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma Hepatology 47 1 105 112 17935223 1:CAS:528: DC%2BD1cXhtlChsrw%3D
50. J Li L Shi X Zhang, et al. 2010 Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivo Cancer Gene Ther 17 11 771 779 20596089 1:CAS:528:DC%2BC3cXotlWku7o%3D
51. G Son T Hirano E Seki, et al. 2006 Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice J Hepatol 45 688 695 16839638 1:CAS:528:DC%2BD28XhtVWqtrzM
52. J Zhao X Zhang M Shi, et al. 2006 TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU Hepatology 44 205 215 16799960 1:CAS:528:DC%2BD28XnsFWjtbk%3D
53. C Yin Y Lin X Zhang, et al. 2008 Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene Hepatology 48 1528 1539 18925631 1:CAS:528:DC%2BD1cXhsVKmtrfF
54. Y Gan J Gu X Cai, et al. 2008 Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cáncer and hepatoma cells both in vitro and in vivo Cancer Gene Ther 15 12 808 816 18617915 1:CAS:528:DC%2BD1cXhtlGrt7%2FO
55. MS Song JS Jeong G Ban, et al. 2009 Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo Cancer Gene Ther 16 2 113 125 18758435 1:CAS:528:DC%2BD1MXkvVGltw%3D%3D
56. T Iida H Shiba T Misawa, et al. 2008 Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma Cancer Sci 99 2097 2103 19016771 1:CAS:528: DC%2BD1cXhsVGltr7K
57. EV Shashkova JF Spencer WSM Wold, et al. 2007 Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus Mol Ther 15 3 598 607 17191072 1:CAS:528:DC%2BD2sXhtVKiu7fF
58. H Mera H Kawashima T Yoshizawa, et al. 2009 Chondromodulin-1 directly suppresses growth of human cancer cells BMC Cancer 9 166 19480713
59. Y Folmer M Schneider HE Blum, et al. 2007 Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs Cancer Gene Ther 14 875 884 17704753 1:CAS:528:DC%2BD2sXhtFChur%2FM
60. G Tian J Liu J Sui 2009 A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization Anticancer Drugs 20 403 407 19318914 1:CAS:528:DC%2BD1MXksV2gu7k%3D
61. J Hu A Dong V Fernandez-Ruiz, et al. 2009 Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma Cancer Res 69 17 6951 6959 19690140 1:CAS:528:DC%2BD1MXhtVOmtL3P
62. V Roh A Laemmle U Von Holzen, et al. 2008 Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma Cancer Gene Ther 15 10 636 644 18535617 1:CAS:528:DC%2BD1cXhtV2isbjE
63. V Schmitz E Raskopf MA Gonzalez-Carmona, et al. 2007 Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model Gut 56 271 278 16809420 1:CAS:528:DC%2BD2sXivF2gtL0%3D
64. C Atorrasagasti M Malvicini JB Aquino, et al. 2010 Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells Int J Cancer 126 2726 2740 19830689 1:CAS:528:DC%2BC3cXjvFKlsb0%3D
65. MM Rodríguez SM Ryu C Qian, et al. 2008 Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression Hum Gene Ther 19 7 753 759 18549308
66. B Boozari B Mundt N Woller, et al. 2010 Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma Gut 59 1416 1426 20675696 1:CAS:528:DC%2BC3cXhtlWhsbzN
67. P Cheng Y Li L Yang, et al. 2009 Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase Oncol Rep 22 1101 1107 19787227 1:CAS:528:DC%2BD1MXhtlCjtbzM
68. R Fan X Li W Du, et al. 2011 Adenoviral-mediated RNa interference targeting URG11 inhibits growth of human hepatocellular carcinoma Int J Cancer 128 12 2980 2993 20725996 1:CAS:528:DC%2BC3MXltVygsb8%3D
69. JL Hsieh CH Lee ML Teo, et al. 2009 Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites model of hepatocellular carcinoma Cancer Sci 100 3 537 545 19134007 1:CAS:528: DC%2BD1MXjt1Wrtbc%3D
70. KW Huang YC Huang KF Tai, et al. 2008 Dual therapeutic effects of interferon-α gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis Mol Ther 16 10 1681 1687 18665156 1:CAS:528:DC%2BD1cXhtFGhs7nL
71. Q Lu DH Yu C Fang, et al. 2009 Influence of E3 region on conditionally replicative adenovirus mediated cytotoxicity in hepatocellular carcinoma cells Cancer Biol Ther 8 12 1125 1132 19448394 1:CAS:528:DC%2BD1MXhs1ahtrbJ
72. L Ma J Liu J Shen, et al. 2010 Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells Cancer Biol Ther 9 7 554 561 20150764 1:CAS:528:DC%2BC3cXhtVGksLbM
73. SH Ma GG Chen J Yip, et al. 2010 Therapeutic effect of α-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice Gene Ther 17 7 905 912 20336154 1:CAS:528:DC%2BC3cXjvVGlsbs%3D
74. G Tian J Liu J Sui, et al. 2009 Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresecable hepatocellular carcinoma: a pilot phase II trial Anticancer Drugs 20 389 395 19287305 1:CAS:528:DC%2BD1MXksV2gu7s%3D
75. XB Xue K Chen CJ Wang, et al. 2008 Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B Hepatobiliary Pancreat Dis Int 7 509 514 18842498 1:CAS:528:DC%2BD1cXhtlSrurvL
76. J Yu B Shen ESH Chu, et al. 2010 Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro Hepatology 51 2008 2019 20512989 1:CAS:528:DC%2BC3cXnslyqtrg%3D
77. R Zhang L Ma M Zheng, et al. 2010 Survivin knockdown by short hairpin RNA abrogated the growth of human hepatocellular carcinoma xenografts in nude mice Cancer Gene Ther 17 275 288 19876077 1:CAS:528:DC%2BD1MXhtlCjtr%2FO
78. B Sangro G Mazzolini M Ruiz, et al. 2010 A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma Cancer Gene Ther 17 12 837 843 20689572 1:CAS:528:DC%2BC3cXpslOitbg%3D
79. X Yang H Zhu Z Hu 2010 Dendritic cells transduced with TEM8 recombinant adenovirus prevents hepatocellular carcinoma angiogenesis and inhibits cells growth Vaccine 28 7130 7135 20650339 1:CAS:528:DC%2BC3cXht1Kqtr3J
80. A Oloumi T McPhee S Dedhar 2004 Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by integrin-linked kinase Biochim Biophys Acta 1691 1 15 15053919 1:CAS:528:DC%2BD2cXisF2gtL8%3D
81. QH Ye LX Qin M Forgues, et al. 2003 Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 4 416 423 12640447 1:CAS:528: DC%2BD3sXisVOmu7o%3D
82. S Huang J He X Zhang, et al. 2006 Activation of the hedgehog pathway in human hepatocellular carcinomas Carcinogenesis 27 7 1334 1340 16501253 1:CAS:528:DC%2BD28XmsVegurk%3D
83. S Tanaka M Mori Y Sakamoto, et al. 1999 Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma J Clin Invest 103 341 345 9927494 1:CAS:528:DyaK1MXovVKnuw%3D%3D
84. T Torimura T Ueno M Kin, et al. 2004 Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma J Hepatol 40 5 799 807 15094228 1:CAS:528:DC%2BD2cXjtFOiurs%3D
85. AT De Souza GR Hankins MK Washington, et al. 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity Nat Genet 11 4 447 449 7493029
86. J Cui X Zhou Y Liu, et al. 2003 Wtn signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes J Gastroenterol Hepatol 18 280 287 12603528 1:CAS:528:DC%2BD3sXjtlKgtrw%3D
87. H Elmileik AC Paterson MC Kew 2005 Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma J Surg Oncol 91 258 263 16121349 1:CAS:528:DC%2BD2MXhtVGlt7vJ
88. K Taniguchi LR Roberts IN Aderca, et al. 2002 Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastoma Oncogene 21 31 4863 4871 12101426 1:CAS:528:DC%2BD38XltVOmu7w%3D
89. Y Ishizaki S Ikeda M Fujimori, et al. 2004 Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas Int J Oncol 24 5 1077 1083 15067328 1:CAS:528:DC%2BD2cXjvVGgu78%3D
90. Y Samuels Z Wang A Bardelli, et al. 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 304 5670 554 15016963 1:CAS:528:DC%2BD2cXjsVGmsbk%3D
91. Y Tanaka F Kanai M Tada, et al. 2006 Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients Oncogene 25 20 2950 2952 16331247 1:CAS:528:DC%2BD28XksVGnsb4%3D
92. KT Yeh JG Chang YJ Chen, et al. 2000 Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma Cancer Invest 18 2 123 129 10705874 1:CAS:528:DC%2BD3cXhvF2kur0%3D
93. M Weihrauch M Benicke G Lehnert, et al. 2001 Frequent k-ras-2 mutations and p16(INK4A) methylation in hepatocellular carcinomas in workers exposed to vinyl chloride Br J Cancer 84 982 989 11286481 1:CAS:528:DC%2BD3MXktVejsr0%3D
94. M Anzola A Sainz N Cuevas, et al. 2004 High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma J Viral Hepat 11 502 510 15500550 1:STN:280:DC%2BD2crjtFaqsw%3D%3D
95. PA Farazi J Glickman J Horner, et al. 2006 Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression Cancer Res 66 4766 4773 16651430 1:CAS:528: DC%2BD28XjvF2ktrg%3D
96. Y Maeta G Shiota J Okano, et al. 2005 Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells Tumour Biol 26 300 305 16254459 1:CAS:528:DC%2BD2MXht1WgtLzF
97. P Chaubert R Gayer A Zimmermann, et al. 1997 Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma Hepatology 25 6 1376 1381 9185756 1:CAS:528:DyaK2sXktV2kt7k%3D
98. H Azechi N Nishida Y Fukuda, et al. 2001 Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinoma Oncology 60 4 346 354 11408803 1:CAS:528:DC%2BD3MXlsFShtb0%3D
99. J Huang HH Sheng T Shen, et al. 2006 Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma FEBS Lett 580 15 3571 3581 16750200 1:CAS:528:DC%2BD28XmtVOmsbo%3D
100. A Marchio M Meddeb P Pineau, et al. 1997 Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization Genes Chromosomes Cancer 18 1 59 65 8993981 1:CAS:528: DyaK2sXnvFKmsw%3D%3D
101. A Pang IO Ng ST Fan, et al. 2003 Clinicopathologic significance of genetic alterations in hepatocellular carcinoma Cancer Genet Cytogenet 146 8 15 14499690 1:CAS:528:DC%2BD3sXnt1Gnsbg%3D
102. T Hanafusa Y Yumoto K Nouso, et al. 2002 Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma Cancer Lett 176 2 149 158 11804742 1:CAS:528:DC%2BD38XmsFGltQ%3D%3D
103. DF Calvisi S Ladu A Gorden, et al. 2006 Ubiquitous activation of Ras and Jak/Stat pathways in human HCC Gastroenterology 130 1117 1128 16618406 1:CAS:528:DC%2BD28XksFWmurg%3D
104. YL Shih RY Shyu CB Hsieh, et al. 2006 Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma Cancer 107 3 579 590 16795071 1:CAS:528:DC%2BD28Xot1aksb4%3D
105. K Fukai O Yokosuka F Imazeki, et al. 2005 Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma Liver Int 25 6 1209 1216 16343074 1:CAS:528:DC%2BD28XkslSrtg%3D%3D
106. W Prangue K Breuhahn F Fischer, et al. 2003 Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes J Pathol 201 2 250 259
107. H Ogata T Kobayashi T Chinen, et al. 2006 Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induces hepatocarcinogenesis Gastroenterology 131 1 179 193 16831601 1:CAS:528:DC%2BD28XnvF2gsb0%3D
108. K Nagao M Tomimatsu H Endo, et al. 1999 Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma J Gastroenterol 34 83 87 10204615 1:CAS:528:DyaK1MXht1entL4%3D
109. MP Seiler V Cerullo B Lee 2007 Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects Curr Gene Ther 7 297 305 17979676 1:CAS:528:DC%2BD1cXhsVKjsA%3D%3D
110. TR Flotte 2007 Gene therapy: the first two decades and the current state-of-the-art J Cell Physiol 213 301 305 17577203 1:CAS:528: DC%2BD2sXhtFKnu73E
111. S Nayak RW Herzog 2010 Progress and prospects: immune responses to viral vectors Gene Ther 17 295 304 19907498 1:CAS:528:DC%2BD1MXhsVSjsrzP
112. Sobrevals L, Enguita M, Rodriguez C, et al. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers. Gene Ther 2012;19(4):411-417
113. F Jacobs E Wisse B De Geest 2010 The role of liver sinusoidal cells in hepatocyte-directed gene transfer Am J Pathol 176 14 21 19948827 1:CAS:528:DC%2BC3cXhs12rsbw%3D
114. N Brunetti-Pierri GE Stapleton DJ Palmer, et al. 2007 Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy Mol Ther 15 732 740 17285138 1:CAS:528: DC%2BD2sXhtVejtLfI
115. A Donsante DG Miller Y Li, et al. 2007 AAV vector integration sites in mouse hepatocellular carcinoma Science 317 477 17656716 1:CAS:528: DC%2BD2sXotFyltLo%3D
116. S Daya KI Berns 2008 Gene therapy using adeno-associated virus vectors Clin Microbiol Rev 21 583 593 18854481 1:CAS:528:DC%2BD1cXhtlClurfN
117. AK Zaiss DA Muruve 2008 Immunity to adeno-associated virus vectors in animals and humans: a continued challenge Gene Ther 15 808 816 18385765 1:CAS:528:DC%2BD1cXmtVamsbw%3D
118. K Lee YG Yun YG Kim, et al. 2006 Adeno-associated virus-mediated expression of apoliprotein (a) kringles suppresses hepatocellular carcinoma growth in mice Hepatology 43 1063 1073 16628632 1:CAS:528:DC%2BD28XkvFGmtLs%3D
119. Z Shen OG Wong RY Yao, et al. 2008 A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma Cancer Lett 272 168 276
120. LY Tse X Sun H Jiang, et al. 2008 Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas J Gene Med 10 508 517 18338836 1:CAS:528:DC%2BD1cXns1ejtbo%3D
121. Y Wang F Huang H Cai, et al. 2010 The efficacy of combination therapy using adeno-associated virus-TRIAL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma J Cancer Res Clin Oncol 136 1827 1837 20213096 1:CAS:528:DC%2BC3cXhtlaqtLzP
122. C Mueller TR Flotte 2008 Clinical gene therapy using recombinant adeno-associated virus vectors Gene Ther 15 858 863 18418415 1:CAS:528:DC%2BD1cXmtVamsbc%3D